(Q44097757)

29 November 2017

title

Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil (English)

1 reference

29 November 2017

0 references

0 references

Marie-Claude Vohl

0 references

Jean-Pierre Després

1 reference

29 November 2017

Yohan Bossé

1 reference

29 November 2017

Agnès Pascot

1 reference

29 November 2017

Martine Dumont

1 reference

29 November 2017

Martin Brochu

1 reference

29 November 2017

Denis Prud'homme

1 reference

29 November 2017

Jean Bergeron

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

311-315

1 reference

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00010

10.1097/00125817-200207000-00010

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 November 2017

1049973465

0 references

1 reference